symmetric dimethylarginine has been researched along with pravastatin in 1 studies
Studies (symmetric dimethylarginine) | Trials (symmetric dimethylarginine) | Recent Studies (post-2010) (symmetric dimethylarginine) | Studies (pravastatin) | Trials (pravastatin) | Recent Studies (post-2010) (pravastatin) |
---|---|---|---|---|---|
428 | 27 | 314 | 3,575 | 1,036 | 816 |
Protein | Taxonomy | symmetric dimethylarginine (IC50) | pravastatin (IC50) |
---|---|---|---|
3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.1452 | |
Insulin receptor | Rattus norvegicus (Norway rat) | 0.0056 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.0056 | |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | 0.0254 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kiefte-de Jong, JC; Nanayakkara, PW; Olthof, MR; Smulders, YM; Stehouwer, CD; Teerlink, T; ter Wee, PM; Twisk, JW; van Guldener, C; van Ittersum, FJ | 1 |
1 trial(s) available for symmetric dimethylarginine and pravastatin
Article | Year |
---|---|
Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD.
Topics: Adult; Aged; Anticholesteremic Agents; Arginine; Carotid Arteries; Chronic Disease; Creatinine; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Kidney Diseases; Lipoproteins, LDL; Male; Middle Aged; Pravastatin; Vitamin B 12; Vitamin B 6; Vitamin E | 2009 |